OncoMed Pharmaceuticals Inc Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 2,500 | 11,400 | 138,937 | |
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 20.01 | 2,500 | 50,021 | 20,642 | 23.1 K to 20.6 K (-10.80 %) |
| Jan 12 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 2,500 | 11,400 | 23,142 | 20.6 K to 23.1 K (+12.11 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.33 | 1 | 21 | 20,642 | 20.6 K to 20.6 K (0.00 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 21.54 | 69 | 1,486 | 20,643 | 20.7 K to 20.6 K (-0.33 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 22.30 | 2,092 | 46,653 | 20,712 | 22.8 K to 20.7 K (-9.17 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 21.33 | 1 | 21 | 33,257 | 33.3 K to 33.3 K (0.00 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 21.54 | 69 | 1,486 | 33,258 | 33.3 K to 33.3 K (-0.21 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 22.30 | 2,092 | 46,653 | 33,327 | 35.4 K to 33.3 K (-5.91 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 21.33 | 1 | 21 | 47,181 | 47.2 K to 47.2 K (0.00 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 21.56 | 69 | 1,488 | 47,182 | 47.3 K to 47.2 K (-0.15 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hoey Timothy | SVP, Cancer Biology | Sell | S | 22.30 | 2,092 | 46,653 | 47,251 | 49.3 K to 47.3 K (-4.24 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 21.54 | 77 | 1,659 | 22,025 | 22.1 K to 22 K (-0.35 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 22.30 | 2,335 | 52,072 | 22,102 | 24.4 K to 22.1 K (-9.56 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.33 | 1 | 21 | 13,377 | 13.4 K to 13.4 K (-0.01 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 21.54 | 52 | 1,120 | 13,378 | 13.4 K to 13.4 K (-0.39 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Hager Alicia J. | VP & General Counse ... | Sell | S | 22.30 | 1,570 | 35,012 | 13,430 | 15 K to 13.4 K (-10.47 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 21.33 | 1 | 21 | 17,838 | 17.8 K to 17.8 K (-0.01 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 21.65 | 69 | 1,494 | 17,839 | 17.9 K to 17.8 K (-0.39 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Patel Sunil | See Remarks | Sell | S | 22.30 | 2,092 | 46,653 | 17,908 | 20 K to 17.9 K (-10.46 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.33 | 1 | 21 | 17,838 | 17.8 K to 17.8 K (-0.01 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 21.56 | 69 | 1,488 | 17,839 | 17.9 K to 17.8 K (-0.39 %) |
| Jan 08 2016 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 22.30 | 2,092 | 46,653 | 17,908 | 20 K to 17.9 K (-10.46 %) |
| Jan 06 2016 | OMED | OncoMed Pharmaceut ... | KARSEN PERRY A | Director | Option Exercise | A | 21.97 | 30,189 | 663,252 | 30,189 |